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1127-l 92 The Outcome of Percutaneous Coronary Interventions 
of Saphenous Vein Grafts in Diabetic Patients 
Compared to Nondiabetic Patients 
Salman Ashfaq, Qahtan Malki, William S. Weintraub. Henry A. Liberman, Anna 
Kalynych, Douglas C. Morris, Emir Veledar, John S. Douglas, Ziyad Ghazzal, Emory 
University, Atlanta, GA 
Background: Percutaneous coronary intervention (PCI) of native coronary arteries is 
known to be associated with more adverse outcomes in diabetics compared to non-dia- 
betics. Whether diabetes is also a marker of less favorable outcomes in saphenous vein 
graft (SVG) interventions has not been well defined in the past. We attempted to deter- 
mine if there were differences in the in-hospital, intermediate, and long term mortality 
rates among diabetic and non-diabetic patients undergoing PCI of saphenous vein grafts. 
Methods: Data on all subjects undergoing PCI at Emory Hospital from 1980 to 2002 was 
collected prospectively and entered into a computerized database. All patients with PCI 
of SVG were included in analysis. There were 3541 SVG parcutaneous interventions 
(2422 in non-diabetics, 1119 in diabetics) performed in 2486 patients. 
Results: At baseline, there were no differences in the rates of angina, or prior history of 
myocardial infarction (MI) in the diabetic and non-diabetic groups. Diabetic patients were 
more likely to be females (27% vs. 17%. pcO.OOOl), to have high blood pressure (75% 
vs. 56%, pcO.OOOl), and to have congestive heart failure (CHF NYHA II-IV) (16.6% vs. 
9.0%, pcO.001). There were more in-hospital deaths in diabetics (2.1% vs. 0.7%, 
p=O.O04). Multivariate predictors of in-hospital mortality were diabetes (HR=3.6. CI=l.7- 
7.5, p=O.O007), CHF NYHA II-IV (HR=3.6. CI=l.6-6.0, p=O.O005), and older age 
(HR=l.04. CI=l.O-1.9, p=O.O2). The incidence of post-PC1 Q-wave Ml was also higher in 
diabetics vs. non-diabetics (1.46% vs. 0.66%), but this did not reach statistical signifi- 
cance (p=O.l5). Diabetic patients had higher 30-day mortality (4.3% vs. 1.9%, p<O.OOOl). 
1 -year survival was worse in the diabetic group (67.4% vs. 94.3%, p<O.OOOl). The 5.year 
survival rate was also worse for the diabetic group (67% vs. 81%, p<O.OOOl). After multi- 
variate analysis, diabetes remained the most important predictor of worse 5-year suwival 
in this population (HR=l.6, Cl=1 S-2.1 p<O.OOOl). 
Conclusion: Diabetic patients undergoing percutaneous intervention of saphenous vein 
grafts have significantly higher in-hospital, intermediate, and long-term mortality com- 
pared to non-diabetics. 
1127-193 Clinical Outcomes After Percutaneous Coronary 
Intervention in Right Ventricular Infarction 
Aditva K. Samal. Tulsidas S. Kuruvanka, Christopher J. White, Stephen R. Ramee, 
Tyrone J. Collins, James S. Jenkins, Ochsner Clinic Foundation, New Orleans, LA 
Background: Right ventricular myocardial infarction (RVMI) adds to the morbidity and 
mortality associated with left ventricular myocardial infarction (LVMI). While the effects of 
timely reperfusion in LVMI are well established, the benefits are less clear with the addi- 
tion of RVMI. We assessed the effect of successful coronary intervention of the occluded 
proximal RCA prior to the origin of the RV branches in patients with acute inferior wall inf- 
arction with and without RVMI. 
Methods: Seventy sewn consecutive patients (61% mate) met the inclusion criteria. 
Thirty Seven (48%) patients had RVMI and 40 (52%) did not (mean age 64.8 +/-13.2 and 
59 +/-12.7 respectively). We compared baseline characteristics and in-hospital outcomes 
(IABP support, arrhythmia, LVEF). and death, nonfatal MI, target vessel revasculariza- 
tion, LVEF at one year between the two groups. 
Results: Both groups had similar baseline characteristics except increased incidence of 
prior CAD in the group without RVMI. There was no significant difference between the 
groups in the use of stent and glycoprotein llblllla antagonists (70.3%, 60%; 41%, 43% 
respectively). 
Conclusion: Despite successful reperfusion. RVMI adds significant morbidity and mortal- 
ity to LVMI. RVMI is associated with higher incidence of in-hospital bradyarrhythmias and 
complete heart block, increased requirement for IABP support, higher one-year death 
rate, and significantly lower LVEF. 
Outcome (+) RVMI (n-37) (-) RVMI (n=40) p-value 
In Hospital N (%) N (%) 
IABP Support 16 (43) 2 (5.0) 0.001 
Arrhythmia 11 (30) 2 (5.0) 0.004 
One Year 
Death 6 (22) 2 (5.3) 0.04 
LVEF >/= 50% 23 (41) 33 (59) 0.04 
1127-194 Predictors of Short- and Long-Term Adverse Outcomes 
Followinn Saohenous Vein Graft Percutaneous 
Coronary Intervention 
Sandeep Nathan, Akshay Gupta, Aaron Satran. Francis 0. Almeda, Lloyd W. Klein, 
Rush-Presbyterian-St. Luke’s Medical Center, Chicago, IL 
Background: In SVG PCI. similar variables may predict both shod and long-term 
adverse events. We evaluated the association between clinical and angiographic vari- 
ables, major ischemic complications and long-term survival in this population. Methods: 
296 consecutive SVG PCl’s (353 lesions) were analyzed for 33 clinical and angiographic 
variables. Periprocedural complications were noted and long-term followup obtained. 
Angiograms ware reviewed in a blinded fashion. Analyses were performed using Pear- 
son’s Chi-square and Cox proportional hazard regression. Results: Major pertprocedural 
ischemic complications occurred in 10.8% of patients; when compared to uncomplicated 
SVG-PCI, complications were associated with older graft age (121 vs 96 mo, p=O.O4), 
type C lesions (89% vs 55%, p<O.OOl), pm-procedure thrombus (54% vs 12%, p<O.OOi), 
and proximal anastomosisigraft body lesion location (100% YS 78%, p~O.Mll). DM 
(RR=l.75. p=O.O5). CHF (RR=l.96. p=O.O2). type C lesions (RR=l.91, p=O.O47) and pre- 
procedural thrombus (RR=2.50, p=O.O03) were independent predictors of death. At a 
mean followup of 34 months long-term survival was significantly lower in patients with 
periprocedural complications. (Fig.1) Conclusions: In SVG PCI older graft age, type C 
lesions, pre-procedure thrombus, and proximal anastomosis/graft body lesions an? asso- 
ciated with periprocedural ischemic complications while DM. CHF, type C lesions, and 
pre-procedural thrombus are independent predictors of mortality. 
1127-195 Impact of Chronic Renal Insufficiency on Long-Term 
Survival Following Percutaneous Coronary Intervention 
Babak A. Vakik, Warren Sherman, Kumar L. Ravi, Timothy A. Sanbom, David L. Brown, 
Beth Israel Medical Center, New York, NY 
Background: Patients with preexisting chronic renal insufficiency &RI) at the time of 
percutaneous coronary intervention (PCI) are at increased risk of procedural and in-hos- 
pital adverse outcomes. However, the impact of CRI on long-term outcomes following 
PCI is lass clear, particularly in the contemporary era of PCI with the availability of stents, 
atheroablative devices and GP Ilb/llla inhibitors. We sought to assess the impact of CRI 
at the time of PCI on long-term survival. Methods: Three hospitals tn New York City con- 
tributed prospectively defined data elements on 4284 pattents undergoing PCI in 1998.9. 
Patients on dialysis were excluded. CRI was defined by serum creatinine > 2.5 mg/dl. All- 
cause mortality at a mean follow-up of 3 years was the primary endpoint. Results: CRI 
was present in 62 patients (1.9%). Patients with CRI ware older than patients without CRI 
(69 vs. 63 years, PcO.001). CRI patients had a greater prevalence of hypertension (63% 
vs. 70%, P=O.O2), diabetes (50% vs. 26%, PcO.OOl), prior heart fallwe (17% vs. 6% 
P<O.OOl), peripheral vascular disease (23% vs. 7%. PcO.001) and prior bypass surgery 
(32% vs. 17%, P<O.OOl). Three-vessel coronary disease was more frequent (35% vs. 
17%, P<O.OOl) and the mean ejection fraction was lower (46% vs. 51%. P=O.OOS) in CRI 
patients. The development of heart failure during admission was 18% among CRI 
patients compared to 5% for patients without CRI (PcO.001). The use of stems and GP 
llbillla inhibitors did not differ significantly between groups. Angiographic SUCCESS was 
97% in both groups. In-hospital monality was 3.3% for patients with CRI compard to 
0.4% for those without CRI (P<O.OOl). At a mean of 3 years follow-up, mortality rate for 
patients with CRI was 40% compared to 8.2% in patients without CRI (Log-rank 
PcO.001). On Cox proporational hazards analysis, CRI was an independent predictor of 
mortaliy (Hazard Ratio, 3.1, 95% Confidence Interval, 1.7-5.5, P<O.OOl). Conclusion: 
CRI at the time of PCI IS independently associated with a 3.fold increase in the hazard of 
death. The increased mortality of CRI patients should stimulate further research concem- 
ing appropriate treatment and surveillance strategies. 
1127-196 The Impact of Body Weight on Outcome After 
Percutaneous Coronary Intervention--The Obesity 
Paradox Revisited: A Report From the National, Heart, 
Lung, and Blood Institute Dynamic Registry 
Janet M. Johnston, Mama1 G. Bourassa, Helen A. Vlachos, Shetyl F. Kelsey. David 0. 
Williams, Kevin E. KIQ Katherine M. Dew, University of Pittsburgh, Pittsburgh, PA, 
University of Montreal, Montreal, PO, Canada 
Background: Recent studies have shown that, paradoxically, overweight and obese indi- 
viduals have a lower risk of in-hospital adverse events and one-year mortality after per- 
cutaneous coronary intervention (PCI) than patients (pts) with normal body mass index 
(BMI). Methods: To reassess the effect of BMI on outcome in a multicenter PCI registry 
we studied 4612 Dynamic Registry pts (24.2% Normal BMl,43.3% Overweight, and 
32.4% Obese). Outcome analysis was performed first for all pts and again after excluding 
smokers and pts with severe concomitant disease. Results: Compared to those with nor- 
mal BMI, both overweight and obese pts were younger and had less concomitant illness 
(p<O.OOl). Conversely, obese individuals had more risk factors for coronary disease 
such as diabetes and hypertension (pcO.001). The extent of coronary disease and the 
mean number of lesions treated was similar across BMI groups. In-hospital death and 
myocardlal infarction (MI) rates were lower with higher BMI. as were mortality rates at 
one year. However, limiting the analysis to non-smokers who presented with no severe 
concomitant disease revealed substantially lower mortality rates and the differential was 
